Abstract
A 52-year-old male with a past medical history of hepatitis C cirrhosis, hypertension, hyperlipidemia, and a body mass index of 34 presents for deceased donor liver transplantation. He has been on the liver transplant list for 6 months. His international normalized ratio (INR) is 2.1, creatinine is 1.6, and total bilirubin is 8.4, and he has never undergone renal replacement therapy. As a result, his preoperative Model for End-Stage Liver Disease (MELD) score is 27. In the holding area, he responds appropriately to most questions, although his wife reports that he has seemed more confused in the past 2 days. On physical exam, you note that the patient is diffusely jaundiced, has spider angiomas, and has marked ascites.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Kamath PS, Kim WR. The model for end-stage liver disease (MELD). Hepatology. 2007;45(3):797–808.
Wagener G, editor. Liver anesthesiology and critical care medicine. New York, NY: Springer; 2013. p. 48–81.
Hofer I, Spivak J, Yaport M, Zerillo J, Reich DL, Wax D, DeMaria S Jr. Association between anesthesiologist experience and mortality after orthotopic liver transplantation. Liver Transpl. 2015;21:89–95.
Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60(8):646–9.
Cholongitas E, Marelli L, Shusang V, Senzolo M, Rolles K, Patch D, Burroughs AK. A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation. Liver Transpl. 2006;12:1049–61.
Tandon P, Ney M, Irwin I, Ma MM, Gramlich L, Bain VG, et al. Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value. Liver Transpl. 2012;18:1209–16.
Organ Procurement and Transplant Network. At-a-Glance: Proposal to Cap the HCC Exception Score at 34.: US Department of Health & Human Services. http://optn.transplant.hrsa.gov/PublicComment/pubcommentPropSub_330.pdf. Published March 14, 2014. Accessed 3 Nov 2015.
Watt K, Lyden E, McCashland T. Poor survival after liver retranplantation: is hepatitis C to blame? Liver Transpl. 2003;9:1019–24.
Coombes J, Trotter JF. Development of the allocation system for deceased donor liver transplantation. Clin Med Res. 2005;3:87–92.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Heller, B., Zerillo, J. (2017). Is the Model for End-Stage Liver Disease (MELD) Score the Best Way to Evaluate Liver Transplant Patients Preoperatively?. In: Scher, C., Clebone, A., Miller, S., Roccaforte, J., Capan, L. (eds) You’re Wrong, I’m Right. Springer, Cham. https://doi.org/10.1007/978-3-319-43169-7_66
Download citation
DOI: https://doi.org/10.1007/978-3-319-43169-7_66
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-43167-3
Online ISBN: 978-3-319-43169-7
eBook Packages: MedicineMedicine (R0)